Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Malaysia

 

Singaporean investor looks to build southeast Asian hospital network

Healthcare Nova talks to the CEO of a Singapore-based private equity group that has put US$100m towards building a hospital network spanning Vietnam, Malaysia, Indonesia, the Philippines, Cambodia and Vietnam, and is set to spend US$100-200m more. The network will encompass elements of a private-public-partnership by building on public land and cater to the middle-class.

Race to buy $1.25bn Fortis Healthcare set for East-West showdown

Malaysian hospital group IHH Healthcare has re-launched its takeover offer for Indian hospital operator Fortis. But it's not the only bidder in a web of rumoured takeovers involving buyers with deep pockets from both the Far East and West. We talk to local contacts.

Qualitas’ IPO plan on Singapore Exchange faces challenges

Malaysia-based outpatient and corporate care group Qualitas’ planned IPO on the Singapore Exchange is “work in progress” and has been delayed to later this year, a well-placed source tells Healthcare Nova. HCN reported at the end of 2017 that Qualitas was planning to list on Singapore Exchange (SGX) to raise S$200m (US$152m) in early 2018. […]

Interview: Dr Rajgopal Thirumalai, Vice President, Global Medical & Occupational Health, Unilever

Unilever runs a global health and prevention programme in over 90 countries for its 169,000  employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.

Interview: Dr Rajgopal Thirumalai, Vice President, Global Medical & Occupational Health, Unilever

Unilever runs a global health and prevention programme in over 90 countries for its 169,000  employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.

Interview: Charles Wang, Group CEO, Luye Medical Group

Formed as recently as 2015, Singapore-based Luye Medical Group has become one of the major contenders in health care services across China, Australia and SE Asia. It is part of the Luye Life Sciences Group which owns Luye Pharma Group, one of the largest pharmaceutical companies in China and separately listed on the Hong Kong Stock Exchange. Luye Medical Group acquired Healthe Care, the third largest Australian for-profit hospital operators in 2016. It has since expanded its business rapidly adding healthcare operations such as oncology (Singapore), inpatient, outpatient and community based health care services (Australia) and rehabilitation and maternity hospitals (China). The aim, says Wang, is mainly to provide a value-based healthcare experience to meet the needs of the middle class and patients with private insurance coverage across SE Asia, Australia and China. Here we talk to him about Luye Medical Group’s plans and how it views the Chinese market. Wang is a speaker at HBI 2018, the global health care service event in London from April 10 to 11.

What do analysts think 2018 has in store for the Thai hospital market?

We talk to analysts about what 2018 has in store for the Thai private hospital market, which is worth around US$5bn. One thinks M&A will pick up domestically, while another thinks the big story will be groups expanding abroad. As for medical tourism, it's set to rise in volume, but fall in value.

Find Us